{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=placebo&page=32", "query": { "intervention": "placebo", "page": 32 }, "page_size": 10 }, "pagination": { "page": 32, "page_size": 10, "total_count": 4142, "total_pages": 415, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=placebo&page=33&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=placebo&page=31&page_size=10" }, "source": "local", "last_synced_at": "2026-10-15T16:42:24.490Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT07213778", "title": "REGN7508 Versus Acetylsalicylic Acid (ASA) for Venous Thromboprophylaxis After Total Knee Arthroplasty in Adult Participants", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Symptomatic Venous Thromboembolism (VTE)" ], "interventions": [ { "name": "Acetylsalicylic Acid (ASA)", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "REGN7508", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Regeneron Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 2000, "start_date": "2025-11-24", "completion_date": "2027-07-16", "has_results": false, "last_update_posted_date": "2026-10-08", "last_synced_at": "2026-10-15T16:42:24.490Z", "location_count": 36, "location_summary": "La Mesa, California • Rancho Mirage, California • Riverside, California + 28 more", "locations": [ { "city": "La Mesa", "state": "California" }, { "city": "Rancho Mirage", "state": "California" }, { "city": "Riverside", "state": "California" }, { "city": "Lone Tree", "state": "Colorado" }, { "city": "Deerfield Beach", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT07213778" }, { "nct_id": "NCT07202884", "title": "A Study of Orforglipron in Female Participants With Stress Urinary Incontinence Who Have Obesity or Overweight", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Urinary Incontinence,Stress" ], "interventions": [ { "name": "Orforglipron", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Eli Lilly and Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 1000, "start_date": "2025-09-30", "completion_date": "2028-03", "has_results": false, "last_update_posted_date": "2026-10-08", "last_synced_at": "2026-10-13T20:28:17.661Z", "location_count": 21, "location_summary": "Birmingham, Alabama • Mobile, Alabama • Mesa, Arizona + 17 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Mesa", "state": "Arizona" }, { "city": "Los Angeles", "state": "California" }, { "city": "Montebello", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT07202884" }, { "nct_id": "NCT07186101", "title": "LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Ulcerative Colitis" ], "interventions": [ { "name": "LY4268989", "type": "DRUG" }, { "name": "LY4268989 Placebo", "type": "DRUG" }, { "name": "Mirikizumab", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Eli Lilly and Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 252, "start_date": "2025-11-10", "completion_date": "2029-03", "has_results": false, "last_update_posted_date": "2026-10-08", "last_synced_at": "2026-10-14T06:45:50.048Z", "location_count": 40, "location_summary": "Scottsdale, Arizona • Anaheim, California • Lancaster, California + 36 more", "locations": [ { "city": "Scottsdale", "state": "Arizona" }, { "city": "Anaheim", "state": "California" }, { "city": "Lancaster", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Colorado Springs", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT07186101" }, { "nct_id": "NCT07174336", "title": "A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Breast Neoplasms", "Neoplasm Metastasis" ], "interventions": [ { "name": "Abemaciclib", "type": "DRUG" }, { "name": "Anastrozole", "type": "DRUG" }, { "name": "Exemestane", "type": "DRUG" }, { "name": "Fulvestrant", "type": "DRUG" }, { "name": "LY4064809", "type": "DRUG" }, { "name": "Letrozole", "type": "DRUG" }, { "name": "Palbociclib", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Ribociclib", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Eli Lilly and Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 800, "start_date": "2025-12-22", "completion_date": "2033-05", "has_results": false, "last_update_posted_date": "2026-10-08", "last_synced_at": "2026-10-14T00:44:09.371Z", "location_count": 129, "location_summary": "Anchorage, Alaska • Chandler, Arizona • Phoenix, Arizona + 110 more", "locations": [ { "city": "Anchorage", "state": "Alaska" }, { "city": "Chandler", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT07174336" }, { "nct_id": "NCT07169851", "title": "A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Drug-Related Side Effects and Adverse Reactions", "Nausea", "Neoplasms", "Vomiting" ], "interventions": [ { "name": "Background Chemotherapy", "type": "DRUG" }, { "name": "LY3537021", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Standard of Care Antiemetic Therapies", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Eli Lilly and Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 204, "start_date": "2025-11-28", "completion_date": "2027-02", "has_results": false, "last_update_posted_date": "2026-10-08", "last_synced_at": "2026-10-13T20:07:24.945Z", "location_count": 20, "location_summary": "Greenbrae, California • Irvine, California • Los Alamitos, California + 17 more", "locations": [ { "city": "Greenbrae", "state": "California" }, { "city": "Irvine", "state": "California" }, { "city": "Los Alamitos", "state": "California" }, { "city": "Walnut Creek", "state": "California" }, { "city": "Fort Collins", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT07169851" }, { "nct_id": "NCT07165028", "title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Metabolic Dysfunction-Associated Steatotic Liver Disease" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "Retatrutide", "type": "DRUG" }, { "name": "Tirzepatide", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Eli Lilly and Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 4500, "start_date": "2025-10-15", "completion_date": "2032-08", "has_results": false, "last_update_posted_date": "2026-10-08", "last_synced_at": "2026-10-14T02:32:41.121Z", "location_count": 141, "location_summary": "Tuscaloosa, Alabama • Chandler, Arizona • Gilbert, Arizona + 122 more", "locations": [ { "city": "Tuscaloosa", "state": "Alabama" }, { "city": "Chandler", "state": "Arizona" }, { "city": "Gilbert", "state": "Arizona" }, { "city": "Peoria", "state": "Arizona" }, { "city": "Sun City", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "nct_id": "NCT07037433", "title": "Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Atherosclerotic Cardiovascular Disease", "Obesity", "Overweight" ], "interventions": [ { "name": "Maridebart Cafraglutide", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Amgen", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "45 Years", "maximum_age": "99 Years", "sex": "ALL", "summary": "45 Years to 99 Years" }, "enrollment_count": 12800, "start_date": "2025-07-25", "completion_date": "2030-09-29", "has_results": false, "last_update_posted_date": "2026-10-08", "last_synced_at": "2026-10-13T21:11:10.005Z", "location_count": 140, "location_summary": "Daphne, Alabama • Fairhope, Alabama • Huntsville, Alabama + 117 more", "locations": [ { "city": "Daphne", "state": "Alabama" }, { "city": "Fairhope", "state": "Alabama" }, { "city": "Huntsville", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Sheffield", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT07037433" }, { "nct_id": "NCT07033494", "title": "A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Early Alzheimer's Disease" ], "interventions": [ { "name": "MK-2214", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "Merck Sharp & Dohme LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "50 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "50 Years to 85 Years" }, "enrollment_count": 340, "start_date": "2025-07-16", "completion_date": "2030-04-30", "has_results": false, "last_update_posted_date": "2026-10-08", "last_synced_at": "2026-10-14T15:04:48.211Z", "location_count": 36, "location_summary": "Irvine, California • Long Beach, California • Los Angeles, California + 32 more", "locations": [ { "city": "Irvine", "state": "California" }, { "city": "Long Beach", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Redlands", "state": "California" }, { "city": "San Francisco", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT07033494" }, { "nct_id": "NCT07015905", "title": "REGN7508 Versus Apixaban and Enoxaparin for Thromboprophylaxis After Total Knee Arthroplasty in Adults", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Venous Thromboembolism (VTE)" ], "interventions": [ { "name": "Apixaban", "type": "DRUG" }, { "name": "Enoxaparin", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "REGN7508", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Regeneron Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 2000, "start_date": "2025-06-25", "completion_date": "2027-05-12", "has_results": false, "last_update_posted_date": "2026-10-08", "last_synced_at": "2026-10-14T00:58:45.319Z", "location_count": 20, "location_summary": "Sheffield, Alabama • Riverside, California • Englewood, Colorado + 16 more", "locations": [ { "city": "Sheffield", "state": "Alabama" }, { "city": "Riverside", "state": "California" }, { "city": "Englewood", "state": "Colorado" }, { "city": "Delray Beach", "state": "Florida" }, { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT07015905" }, { "nct_id": "NCT07011745", "title": "A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Alzheimer's Disease" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "Xanomeline Enteric Capsule", "type": "DRUG" }, { "name": "Xanomeline/Trospium Chloride Capsule", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Bristol-Myers Squibb", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "55 Years", "maximum_age": "90 Years", "sex": "ALL", "summary": "55 Years to 90 Years" }, "enrollment_count": 426, "start_date": "2025-07-16", "completion_date": "2028-11-13", "has_results": false, "last_update_posted_date": "2026-10-08", "last_synced_at": "2026-10-14T14:34:17.598Z", "location_count": 42, "location_summary": "Chandler, Arizona • Garden Grove, California • Long Beach, California + 35 more", "locations": [ { "city": "Chandler", "state": "Arizona" }, { "city": "Chandler", "state": "Arizona" }, { "city": "Chandler", "state": "Arizona" }, { "city": "Garden Grove", "state": "California" }, { "city": "Long Beach", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT07011745" } ] }